Jacob S. Brenner, Ph.D. - Publications

Affiliations: 
Stanford University, Palo Alto, CA 

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Glassman PM, Myerson JW, Ferguson LT, Kiseleva RY, Shuvaev VV, Brenner JS, Muzykantov VR. Targeting drug delivery in the vascular system: Focus on endothelium. Advanced Drug Delivery Reviews. PMID 32579890 DOI: 10.1016/J.Addr.2020.06.013  0.337
2020 Glassman PM, Villa CH, Ukidve A, Zhao Z, Smith P, Mitragotri S, Russell AJ, Brenner JS, Muzykantov VR. Vascular Drug Delivery Using Carrier Red Blood Cells: Focus on RBC Surface Loading and Pharmacokinetics. Pharmaceutics. 12. PMID 32397513 DOI: 10.3390/Pharmaceutics12050440  0.3
2018 Parhiz H, Shuvaev VV, Pardi N, Khoshnejad M, Kiseleva RY, Brenner JS, Uhler T, Tuyishime S, Mui BL, Tam YK, Madden TD, Hope MJ, Weissman D, Muzykantov VR. PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 30336167 DOI: 10.1016/J.Jconrel.2018.10.015  0.302
2018 Brenner JS, Pan DC, Myerson JW, Marcos-Contreras OA, Villa CH, Patel P, Hekierski H, Chatterjee S, Tao JQ, Parhiz H, Bhamidipati K, Uhler TG, Hood ED, Kiseleva RY, Shuvaev VS, et al. Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude. Nature Communications. 9: 2684. PMID 29992966 DOI: 10.1038/S41467-018-05079-7  0.308
2017 Brenner JS, Kiseleva RY, Glassman PM, Parhiz H, Greineder CF, Hood ED, Shuvaev VV, Muzykantov VR. EXPRESS: The new frontiers of the targeted interventions in the pulmonary vasculature: precision and safety. Pulmonary Circulation. 2045893217752329. PMID 29261028 DOI: 10.1177/2045893217752329  0.33
2017 Brenner JS. Nanomedicine for the Treatment of Acute Respiratory Distress Syndrome: The 2016 ATS Bear Cage Award-Winning Proposal. Annals of the American Thoracic Society. PMID 28304180 DOI: 10.1513/Annalsats.201701-090Ps  0.315
2015 Shuvaev VV, Brenner JS, Muzykantov VR. Targeted endothelial nanomedicine for common acute pathological conditions. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 26435455 DOI: 10.1016/J.Jconrel.2015.09.055  0.339
2015 Myerson JW, Brenner JS, Greineder CF, Muzykantov VR. Systems approaches to design of targeted therapeutic delivery. Wiley Interdisciplinary Reviews. Systems Biology and Medicine. PMID 25946066 DOI: 10.1002/Wsbm.1304  0.335
2007 Brenner JS, Dolmetsch RE. TrpC3 regulates hypertrophy-associated gene expression without affecting myocyte beating or cell size. Plos One. 2: e802. PMID 17726532 DOI: 10.1371/Journal.Pone.0000802  0.573
2007 Brenner J, Gomez-Ospina N, Dolmetsch R. Temporal and spatial regulation of calcium-dependent transcription New Comprehensive Biochemistry. 41: 403-423. DOI: 10.1016/S0167-7306(06)41015-2  0.531
Show low-probability matches.